François Martin

12.3k total citations · 5 hit papers
72 papers, 7.8k citations indexed

About

François Martin is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, François Martin has authored 72 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 25 papers in Oncology and 18 papers in Molecular Biology. Recurrent topics in François Martin's work include Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (18 papers) and Cancer Immunotherapy and Biomarkers (14 papers). François Martin is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (18 papers) and Cancer Immunotherapy and Biomarkers (14 papers). François Martin collaborates with scholars based in France, Canada and United States. François Martin's co-authors include François Ghiringhelli, Sylvain Ladoire, Éric Solary, Bruno Chauffert, Lionel Apétoh, Laurence Zitvogel, Lloyd R. Sutherland, Cédric Menard, S. Roux and Arnaud Parcellier and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

François Martin

72 papers receiving 7.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity

2010 969 citations Julie Vincent, Grégoire Mignot et al. Cancer Research profile →
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

2006 968 citations François Ghiringhelli, Cédric Menard et al. Cancer Immunology Immunotherapy profile →
CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

2004 706 citations François Ghiringhelli, Nicolas Larmonier et al. European Journal of Immunology profile →
Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation

2005 588 citations François Ghiringhelli, S. Roux et al. The Journal of Experimental Medicine profile →
5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1987 552 citations Lloyd R. Sutherland, François Martin et al. profile →

Peers

François Martin

IMMUN

ONCOL

GENET

EPIDE

Veena Kapoor United States

Robert H. Wiltrout United States

Christoph Huber Germany

Marij J.P. Welters Netherlands

Albert F. LoBuglio United States

Ferdy J. Lejeune Switzerland

Jeffrey A. Ledbetter United States

Isabelle Cremer France

Jing Sun China

Kevin F. Staveley-O’Carroll United States

Veena Kapoor United States

François Martin

6.1k ×1.4

IMMUN

5.2k ×1.4

ONCOL

2.5k ×1.6

916 ×0.7

GENET

693 ×0.6

EPIDE

Citations per year, relative to François Martin François Martin (= 1×) peers Veena Kapoor

Countries citing papers authored by François Martin

Since Specialization

Citations

This map shows the geographic impact of François Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Martin more than expected).

Fields of papers citing papers by François Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Martin. The network helps show where François Martin may publish in the future.

Co-authorship network of co-authors of François Martin

This figure shows the co-authorship network connecting the top 25 collaborators of François Martin. A scholar is included among the top collaborators of François Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Martin. François Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Murphy, Diarmaid J., Clare F. McCoy, Peter D. W. Boyd, et al.. (2022). In vitro drug release, mechanical performance and stability testing of a custom silicone elastomer vaginal ring releasing dapivirine and levonorgestrel. International Journal of Pharmaceutics X. 4. 100112–100112. 6 indexed citations

Végran, Frédérique, François Martin, Lionel Apétoh, & François Ghiringhelli. (2016). Les lymphocytes Th9. médecine/sciences. 32(4). 387–393. 4 indexed citations

Ladoire, Sylvain, François Martin, & François Ghiringhelli. (2011). Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer. Cancer Immunology Immunotherapy. 60(7). 909–918. 263 indexed citations

Ladoire, Sylvain, Grégoire Mignot, Tienhan Sandrine Dabakuyo‐Yonli, et al.. (2011). In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival. The Journal of Pathology. 224(3). 389–400. 185 indexed citations

Vincent, Julie, Grégoire Mignot, Fanny Chalmin, et al.. (2010). 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity. Cancer Research. 70(8). 3052–3061. 969 indexed citations breakdown →

Roux, S., Lionel Apétoh, Fanny Chalmin, et al.. (2008). CD4+CD25+ Tregs control the TRAIL-dependent cytotoxicity of tumor-infiltrating DCs in rodent models of colon cancer. Journal of Clinical Investigation. 118(11). 3751–3761. 50 indexed citations

Guilly, Marie‐Noëlle, André Bouchot, Nathalie Droin, et al.. (2008). Tumor cells can escape DNA‐damaging cisplatin through DNA endoreduplication and reversible polyploidy. Cell Biology International. 32(9). 1031–1043. 213 indexed citations

Menard, Cédric, François Martin, Lionel Apétoh, Florence Bouyer, & François Ghiringhelli. (2008). Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity. Cancer Immunology Immunotherapy. 57(11). 1579–1587. 129 indexed citations

Larmonier, Nicolas, Delphine Mérino, Dominique Cathelin, et al.. (2006). Apoptotic, necrotic, or fused tumor cells: An equivalent source of antigen for dendritic cell loading. APOPTOSIS. 11(9). 1513–1524. 33 indexed citations

10.

Ghiringhelli, François, Cédric Menard, Sylvain Ladoire, et al.. (2006). Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunology Immunotherapy. 56(5). 641–648. 968 indexed citations breakdown →

11.

Ghiringhelli, François, S. Roux, Arnaud Parcellier, et al.. (2005). Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4 + CD25 + regulatory T cell proliferation. The Journal of Experimental Medicine. 202(7). 919–929. 588 indexed citations breakdown →

12.

Ghiringhelli, François, Nicolas Larmonier, E. Schmitt, et al.. (2004). CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. European Journal of Immunology. 34(2). 336–344. 706 indexed citations breakdown →

13.

Martin, François & Éric Solary. (2004). Tumor Cell Resistance to DNA-Damaging Agents: From Apoptosis to Neiosis. PubMed. 4(5). 461–463. 8 indexed citations

14.

Larmonier, Nicolas, François Ghiringhelli, Claire B. Larmonier, et al.. (2003). Freshly isolated bone marrow cells induce death of various carcinoma cell lines. International Journal of Cancer. 107(5). 747–756. 19 indexed citations

15.

Bonnotte, Bernard, Nicolas Larmonier, Nathalie Favre, et al.. (2001). Identification of Tumor-Infiltrating Macrophages as the Killers of Tumor Cells After Immunization in a Rat Model System. The Journal of Immunology. 167(9). 5077–5083. 61 indexed citations

16.

Fromentin, Annie, et al.. (2000). Cutting Edge: The Tumor Counterattack Hypothesis Revisited: Colon Cancer Cells Do Not Induce T Cell Apoptosis Via the Fas (CD95, APO-1) Pathway. The Journal of Immunology. 164(10). 5023–5027. 65 indexed citations

17.

Martin, François, et al.. (1994). Cd4+ T cells recovered from a mixed immune lymphocyte‐tumor cell culture induce thymidine incorporation by naive rat lymphocytes in response to tumor cells. International Journal of Cancer. 57(2). 254–258. 3 indexed citations

18.

Greenberg, Gordon R., Brian G. Feagan, François Martin, et al.. (1994). Oral Budesonide for Active Crohn's Disease. New England Journal of Medicine. 331(13). 836–841. 413 indexed citations

19.

Pèlegrin, André, Daniel Hayoz, Yves Chalandon, et al.. (1992). Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats. International Journal of Cancer. 52(1). 110–119. 17 indexed citations

20.

Olsson, Nils‐Olivier, et al.. (1991). Cytotoxic Activity of Lymphocytes Infiltrating Progressive and Regressive Tumor Variants from a Rat Colonic Cancer. Immunobiology. 182(2). 188–196. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact